1. Home
  2. RPD vs AMPH Comparison

RPD vs AMPH Comparison

Compare RPD & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPD
  • AMPH
  • Stock Information
  • Founded
  • RPD 2000
  • AMPH 1996
  • Country
  • RPD United States
  • AMPH United States
  • Employees
  • RPD N/A
  • AMPH N/A
  • Industry
  • RPD Computer Software: Prepackaged Software
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • RPD Technology
  • AMPH Health Care
  • Exchange
  • RPD Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • RPD 1.5B
  • AMPH 1.1B
  • IPO Year
  • RPD 2015
  • AMPH 2014
  • Fundamental
  • Price
  • RPD $23.40
  • AMPH $21.70
  • Analyst Decision
  • RPD Hold
  • AMPH Hold
  • Analyst Count
  • RPD 19
  • AMPH 5
  • Target Price
  • RPD $32.94
  • AMPH $38.00
  • AVG Volume (30 Days)
  • RPD 892.5K
  • AMPH 501.2K
  • Earning Date
  • RPD 08-07-2025
  • AMPH 08-06-2025
  • Dividend Yield
  • RPD N/A
  • AMPH N/A
  • EPS Growth
  • RPD N/A
  • AMPH N/A
  • EPS
  • RPD 0.41
  • AMPH 2.77
  • Revenue
  • RPD $849,159,000.00
  • AMPH $730,659,000.00
  • Revenue This Year
  • RPD $2.81
  • AMPH $0.67
  • Revenue Next Year
  • RPD $4.05
  • AMPH $5.18
  • P/E Ratio
  • RPD $56.39
  • AMPH $7.83
  • Revenue Growth
  • RPD 6.19
  • AMPH 8.05
  • 52 Week Low
  • RPD $21.61
  • AMPH $21.48
  • 52 Week High
  • RPD $44.48
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • RPD 46.92
  • AMPH 28.01
  • Support Level
  • RPD $23.83
  • AMPH $22.81
  • Resistance Level
  • RPD $25.85
  • AMPH $23.77
  • Average True Range (ATR)
  • RPD 0.90
  • AMPH 0.76
  • MACD
  • RPD 0.08
  • AMPH -0.20
  • Stochastic Oscillator
  • RPD 25.53
  • AMPH 9.27

About RPD Rapid7 Inc.

Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: